KOL Interview: Mr. Torisawa from Helios Corporation

[User Interview] Helios Corporation. Live cell analysis that doesn't miss cellular behavior! Aiming to develop cancer treatment methods using NK cells.

Helios Co., Ltd., which develops regenerative pharmaceuticals using iPS cell technology, creates NK cells with enhanced functions through gene introduction and editing from iPS cells, and conducts research and development of immunotherapy for a wide range of cancer diseases. Yusuke Torisawa, an expert in the company's research department's exploratory research group, felt the difficulty of capturing movements such as migration functions while evaluating NK cells for cancer treatment under a microscope. At that time, he encountered our "Incucyte SX5 Live Cell Analysis System," which he says solved various challenges and accelerated research. *For detailed interview content, please refer to the PDF. For more information, feel free to contact us.*

Other Analysis